Unlike coronary artery disease, VHD is relatively understudied in this context - we hope our work adds meaningful data in this area.

Huge thanks to two amazing med students — Dr. Lye Yan Nerng (now graduated) and Chen Haoyang (soon to graduate) — for making this possible!

2) 1 in 8 ESKD patients develop de novo or progressive VHD after referral for the waitlist
3) Unsurprisingly, both baseline and incident VHD predicted mortality
4) Age, time on dialysis and CKD-MBD factors independently predicted baseline and incident VHD

- Achieving Early Target Trough Levels of Tacrolimus Using CYP3A5-Guided versus Standard Weight-Based Dosing in a Multi-Ethnic Cohort of Kidney Transplant Recipients in Singapore (Abstract# P2.12.6)

- Rise and Fall of Donor-Derived Cell-Free DNA Following Treatment of Antibody-Mediated Rejection in Asian Kidney Transplant Recipients (Abstract# P1.07.249)

Poster presentations
- Real-World Application of dd-cfDNA in Screening for Rejection and Post-Treatment Monitoring in Asian Kidney Transplant Patients (Abstract# P3.07.201)

Rapid fire oral presentation
- National Trends of Sex Disparity over 5 Decades of Living Donor Kidney Transplantation in Singapore (Abstract# RF07.3)

Another interrim analysis from our #TTV on our vintage/prevalent #kidneytransplant population. Expect final analysis to be available (hopefully) Q4 2025 to Q1 2026

Sharing our experience using the Highway1 from Cellular Highways (which has been acquired by @stemcell.com) for preenrichment before sorting for human #Tregs